Results 1 to 10 of about 445,656 (308)

GASTRIC CANCER [PDF]

open access: greenSouthern Medical Journal, 1917
n ...
W A Bryan
openalex   +4 more sources

Risks and benefits of additional surgery for early gastric cancer in the upper third of the stomach meeting non-curative resection criteria after endoscopic submucosal dissection

open access: yesWorld Journal of Surgical Oncology, 2022
Background Additional surgery is recommended after non-curative endoscopic submucosal dissection for early gastric cancer. However, it is not easy to recommend for tumors located in the upper third of the stomach, because it would be a total or proximal ...
Sin Hye Park   +5 more
doaj   +1 more source

The prognostic impact of macroscopic serosal change on resectable advanced gastric cancer

open access: yesBMC Cancer, 2021
Background Advanced gastric cancer sometimes causes macroscopic serosal change (MSC) due to direct invasion or inflammation. However, the prognostic significance of MSC remains unclear.
Masahiro Yura   +7 more
doaj   +1 more source

Acceleration of sarcopenia in elderly patients who develop asymptomatic pneumonia shadow within one year after surgery for early gastric cancer

open access: yesBMC Surgery, 2023
Background Although early gastric cancer is curable with local treatment, the overall survival in elderly patients did not reach 80% at five years after surgery.
Ayako Kamiya   +8 more
doaj   +1 more source

Long-term postoperative pneumonia in elderly patients with early gastric cancer

open access: yesBMC Surgery, 2022
Background Pneumonia is a major cause of death in the elderly population. Considering body weight loss, muscle loss, and reflux after gastrectomy, elderly patients are considered to be at very high risk for pneumonia, which could decrease overall ...
Ayako Kamiya   +8 more
doaj   +1 more source

Gastric cancer [PDF]

open access: yesThe Lancet, 2009
Gastric cancer is the second most frequent cause of cancer death worldwide, although much geographical variation in incidence exists. Prevention and personalised treatment are regarded as the best options to reduce gastric cancer mortality rates. Prevention strategies should be based on specific risk profiles, including Helicobacter pylori genotype ...
Hartgrink, HH   +3 more
openaire   +3 more sources

Laparoscopic approach to early gastric cancer in a patient with a prior history of open right hepatectomy: a case report

open access: yesSurgical Case Reports, 2020
Background Laparoscopic gastrectomy is regarded a standard treatment procedure for early gastric cancer and is widely used in clinical practice. However, the feasibility of laparoscopic gastrectomy for patients with a prior history of open surgery ...
Ko Ikegame   +5 more
doaj   +1 more source

Gastric Cancer [PDF]

open access: yesBritish Medical Bulletin, 2008
Gastric cancer remains a major cause of mortality and morbidity worldwide, and the total number of gastric cancer cases is predicted to rise as a result of population growth. The pathogenesis of gastric cancer represents a paradigm for microbially induced and inflammation-driven malignancies, and understanding this will be the best means of defeating ...
Paul, Lochhead, Emad M, El-Omar
openaire   +3 more sources

Avelumab in Gastric Cancer [PDF]

open access: yesImmunotherapy, 2019
Gastric cancer (GC) is the fifth most common malignancy and the third cause of cancer-related deaths worldwide. Currently, surgery and chemotherapy remain the main therapeutic options and the prognosis of the disease is still poor in the metastatic setting.
Roviello G.   +7 more
openaire   +5 more sources

Predictive value of the surgical Apgar score on postoperative complications in advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by radical gastrectomy: a single-center retrospective study

open access: yesBMC Surgery, 2020
Background The surgical Apgar score (SAS) or modified SAS (mSAS) has been reported as a simple and easy risk assessment system for predicting postoperative complications in primary surgery for gastric cancer. However, few studies have described the SAS’s
Masato Hayashi   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy